Beta-Blocker Heart Attack Trial (BHAT)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1977

Study Completion Date

October 31, 1981

Conditions

ArrhythmiaCardiovascular DiseasesCoronary DiseaseDeath, Sudden, CardiacHeart DiseasesMyocardial InfarctionMyocardial IschemiaVentricular Fibrillation

Interventions

DRUG

propranolol

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000492 - Beta-Blocker Heart Attack Trial (BHAT) | Biotech Hunter | Biotech Hunter